DCM gene. Two of the identified mutations are missense located in the BAG domain of BAG3 known to interact with the chaperone Hsp70 (Heat Shock Protein 70). BAG3 is a cytoprotective co-chaperone involved in proteostasis, and plays a role in autophagic clearance of misfolded or degraded proteins. The aim of the study is to confirm that BAG3 mutations are responsible for DCM and to identify underlying molecular mechanisms. We studied biochemical and cellular effects of these mutations in rat neonatal cardiomyocytes (RNC) and HeLa cells, with transient overexpression of GFP-fused BAG3 proteins. Fusion protein location was observed by immunofluorescent microscopy. BAG3-wt/mut overexpression in RNC lead to normal expression at the Z-disc. However 48 hours post-transfection, RNC overexpressing BAG3-mut displayed cellular atrophy and disorganized sarcomeres. Potential perturbation of BAG3 partner interaction was investigated using GST pull-down, which demonstrated a loss of BAG3-mut/Hsp70 interaction. The effect of BAG3 mutations on autophagy was examined via western-blot monitoring LC3-II and on proteostasis using a luciferase based reporter assay. These experiments demonstrated that BAG3-mut overexpression, under stress conditions, seems to alter proteostasis regulation. These results suggest an effect of BAG3 mutants on cardiomyocyte survival, with a faulty proteostasis response to proteotoxic stress, which could be linked to a loss of chaperone interaction. It reveals a new putative pathological mechanism leading to DCM.
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Biglcan is beneficial in angiotensin II induced heart failure by preventing cardiac inflammation and remodeling improving LV function and mortality by preventing transdifferentiation of myofibroblasts Biglycan is a small leucine rich proteoglycan and is important for the structural integrity of the extracellular matrix, but also serves as a danger signal and triggers sterile inflammation. Whether biglycan is beneficial or delirious in angiotensin induced heart failure, a model were remodeling as well as inflammation plays a crucial role, is unkown. The present study investigated whether gene deletion of biglycan influences cardiac inflammatory stress response, adverse remodeling as well as apoptosis leading to cardiac dysfunction and mortality after 3 weeks of angiotensin induced heart failure in vivo. Methods and results: Biglycan knockout mice (BGN-/-) and their controls (WT) were subjected to receive angiotensin II (ANGII) or saline for 3 weeks via osmotic mini pump and 21 days later LV function was analyzed invasively. ANGII induced significant cardiac inflammation (increased CD3 (+3.5 fold) and CD11b+ (+5 fold) cells) as well as cardiac dysfunction in WT-ANGII animals. Interestingly, deletion of BGN impaired cardiac function (significantly impaired stroke work, cardiac output and diastolic function) when BGN-/-ANGII were compared to WT-ANGII. This was associated with increased inflammation (CD3, CD11, cytokine expression TNF-alpha) as well as increased collagen accumulation as detrimental LV remolding in BGN-/-ANGII compared to WT-ANGII. This all increased mortality in BGN-/-ANGII (45% vs 0%) in ANGII induced heart failure. Interestingly, we documented an increased number of myofibroblasts in BGN-/-ANGII, which might explain the accumulation of matrix as well as increased inflammatory response compared to WT-ANGII Conclusions: Loss of biglycan increased the inflammatory response, which impaired cardiac remodeling and function during ANGII induced heart failure leading to high mortality in vivo. Therefore, biglycan in ANGII induced heart failure seems to be beneficial by preserving the structural integrity of the matrix and preventing increased transdifferentiation of fibroblasts to myofibroblasts.
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Endonuclease G modulates myocardial energy metabolism and function at advanced age 
Background:
We have recently shown that endonuclease G (Endo G) is localized in heart mitochondria and necessary for mitochondrial DNA homeostasis and respiration, and modulates cardiomyocyte size. In the present study we investigated the impact of EndoG deficiency on myocardial function and its relation with age. Methods and results: Studies were performed in EndoG-KO mice and wildtype littermates (WT) of two ages: adults (6-12 months) and old (>24 months). In adult animals, blood pressure monitoring (telemetry) demonstrated no differences between EndoG-KO and WT (mean blood pressure 118.2±4.2 vs 112,2±6.9 mmHg, p = ns), and P NMR spectroscopy of isolated, perfused hearts showed no differences in ATP/creatine phosphate (CrP) ratio ( 
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The immune protein MD-2 is a novel independent predictor for long term mortality in dilated cardiomyopathy and non-inferior to nt-pro BNP Background: Myeloid Differentiation protein 2 (MD-2) is strongly involved in activation of the innate immune receptor Toll-Like Receptor 4 (TLR4). Its role in cardiac diseases is unknown. Since cardiac inflammation is often associated with heart failure, we investigated in the present study the impact of MD-2 level at first hospital admission in patients with Dilated Cardiomyopathy (DCM) on long term mortality.
Methods and results:
We included 174 patients between 2005 and 2011 with biopsy-proven DCM in our study. MD-2 protein expression in serum from patients was quantified by ELISA (USCN Life Science, USA) and nt-pro brain natriuretic peptide (nt-pro BNP) level were quantified during routine diagnostics at first hospital admission. The primary end point of this study was all-cause mortality. Information on vital status of patients was obtained from official resident data files. For descriptive statistics the study population was divided into two groups according to the patients' MD-2 measurement (≥ and < median of all patients). Survival analysis was done calculating Kaplan-Meier curves and log-rank test was used for curve comparison. Multivariable Cox regression models were applied to assess the association between MD-2 level and all-cause mortality, with adjustment for age and cardiovascular risk factors. A value of p < 0.05 was considered statistically significant. All-cause mortality in DCM patients with MD-2 level ≥ overall median (302.44 ng/ml) was strongly associated with increased mortality when compared to patients with MD-2 level < overall median (31.0% versus 8.1%, p<0.001). Multivariable Cox regression analyses demonstrate, that this effect was independent from age, LV ejection fraction and other cardiovascular risk factors including diabetes, BMI, arterial systolic and diastolic blood pressure and smoking with a hazard ratio of 1.004 (p<0.001) for MD-2 as continuous variable. ROC analyses showed no statistically difference between prediction of mortality regarding MD-2 vs. nt-pro BNP (AUC: 0.79 versus 0.74, p=0.40). Conclusion: MD-2, quantified at first hospital admission, is an independent predictor for mortality in DCM and is non-inferior to nt-pro BNP suggesting a relevant role of this protein in the pathophysiology of DCM.
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The association of cardiovascular reactivity to mental stress with mortality in patients with chronic heart failure N. Kupper, L. Smeijers, W.J. Kop. Tilburg University, CoRPS Center of Research on Psychology in Somatic diseases, Tilburg, Netherlands Objective: Psychological factors have been related to poor outcome in patients with heart failure. Pathophysiological mechanisms explaining this link may include the cardiovascular response to acute mental stress. The current study examined whether heart rate and blood pressure responses to acute mental stress predicted mortality in patients with chronic heart failure. Methods: Patients with HF (N=100, 26% female, mean age 65±12 years) underwent a public speech task, during which heart rate (HR) and blood pressure (BP) were recorded. Their all cause mortality status was assessed 4.8 years thereafter. Heart rate reactivity was recoded into high, low, and negative responsiveness based on the 25th (bpm ≤0) and 75th (>6 bpm) percentile. Blood pressure reactivity was recoded in high (>12.1 mmHg), medium (2.3-12.1 mmHg) and low (<2.3 mmHg) responsiveness based on the 25th and 75th percentile. The following covariates were added to the Cox proportional hazards regression: gender, left ventricular ejection fraction, use of beta blocking agents (HR), use of ACEi/ARB medication (BP), and presence of implanted devices. A p value of <.10 was considered of interest, due to the limited sample size. Results: At follow-up, 31 patients had died (31%), of whom 15 from cardiac causes. Results from the Cox proportional hazards regression showed that blunted HR reactivity (between 0.5-6 bpm; HR=2.3, 95% CI=0.9-6.2, p=.09) and low diastolic BP reactivity (HR=3.1, 95% CI=1.3-7.9, p=.02) were significantly associated with an increased risk of mortality in HF independent of included covariates (all ns, except ACEi/ARB use (HR=0.3, 95% CI=0.1-0.8, p=.02)). SBP reactivity was not significantly related to future mortality risk. Conclusion: In this preliminary study, low heart rate and diastolic blood pressure reactivity to acute mental stress were independent associates of all cause mortality in patients with chronic heart failure. The observed blunted autonomic and hemodynamic response to mental stress is in accordance with physical stress reactivity. These findings call for replication by larger studies that also should examine whether mental stress reactivity is a mediator in the relation between psychological risk factors and adverse cardiac outcomes.
HEART FAILURE: PATHOPHYSIOLOGY AND PROGNOSIS Purpose: To study diagnostic and prognostic value of Multislice Computed Tomography (MSCT) in patients with dilated cardiomyopathy in comparison with myocardial biopsy. Methods: 88 patients (65 men, 47.2±11.7 years) with dilated cardiomyopathy (mean left ventricle diastolic diameter 6.7±0.9 cm, LVEF 28.0±10.5%) had 320-row MSCT, in 21 patients morphological study (endomyocardial/intraoperative biopsy, autopsy or explanted heart examination) was also performed. Anti-heart antibodies were also measured as well as virus detection, EchoCG, scintigraphy (n=23), MRI (n=10), coronary angiography (n=36) were performed. Results: Areas of low contrast enhancement were found in 8 patients (9.1%, 1 point), myocardial late enhancement in 40 (45.5%): subendocardial, 16 (2 points), subepicardial, 17 (3 points), transmural, 16 (4 points). In addition, fat in the right (n=3, 3.4%) and both ventricles (n=2, 2.3%), noncompact myocardium of the left ventricle (n=16, 18.2%), myocardial late enhancement in aorta (n=1, 1.1%), coronary artery stenosis more 50% (n=10, 11.4%), vascular anomalies (n=3, 3.4%), including massive pelvic arteriovenous malformation as a cause of hypervolemic dilated cardiomyopathy were found. The sensitivity and specificity of the subepicardial/transmural enhancement for myocarditis diagnostics were 55% and 100% with biopsy and 44.9% and 84.6% with combined study, respectively. Myocarditis was diagnosed based on combined study in all patients with coronary atherosclerosis (MSCT), late subepicardial/ transmural enhancement was found in 4 cases (40%); coronary angiography has not confirmed significant stenoses in 3 patients. Different types of contrast enhancement on the scale 0-4 points correlated with: 1) morphological findings: more than 14 infiltrating cells (r=0. Purpose: To evaluate the interest of BNP for heart failure (HF) diagnosis in very old patients. Methods: The BED Study is a French multicenter observational prospective study that enrolled 383 very old patients (≥ 80 y) hospitalized in geriatric care with acute dyspnea. BNP was measured in acute phase, before any diuretic treatment. Cardiologists, blinded for BNP values, classified the patients into 3 subgroups according to ESC criteria: HF, respiratory failure and mixed disease (HF and respiratory). The discriminating value of BNP for HF diagnosis was assessed by sensibility, sensitivity and area under ROC curve (AUC). For the discriminating analysis, patients with mixed dyspnea were first reclassified into HF or respiratory failure groups according to the predominant feature and were further excluded for sensitivity analysis. Results: Mean age was 89±5 years, 66% of patients were women, 57% had history of HF, 67% hypertension, 13% diabetes, 33% coronary heart disease and 49% atrial fibrillation. Mean LVEF was 56±13%. Several patients had non-cardiac comorbidities including malnutrition (48%), severe renal failure (41%), dementia (38%), COPD (17%), and cancer (12%). The diagnosis categories were HF (50%), respiratory dyspnea (26%) and mixed dyspnea (24%). The mean BNP values for these 3 categories were 675 (835), 301 (366), 558 (796) pg/mL respectively (p<0.001). However, the AUC was only 0.68. In the overall population, the sensitivity and specificity was 86% and 33% for a cutoff of 100 pg/mL, 48% and 73% for a cutoff of 400 pg/mL and 26% and 86% for a cutoff of 800 pg/mL. Similar results were obtained after exclusion of patients with mixed dyspnea. Conclusion: In very old patients, BNP is poorly discriminant for the diagnosis of acute dyspnea.
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Effect of heart failure induced by pacing on HDL levels and cellular cholesterol efflux in a model of minipig Purpose: Clinical, experimental and in vitro studies suggest a major role for highdensity lipoproteins (HDL) and their major apolipoprotein component (ApoA1) in the vascular homeostasis regulation on ischemic etiology of heart failure (HF), not necessarily related to pro-or anti-atherosclerotic mechanisms. Low HDL, together with a pro-inflammatory state, seem to be associated with left ventricular dysfunction in the absence of coronary atherosclerotic lesions, as occurs in idiopathic dilated cardiomyopathy. To analyze the alterations induced by pacing on lipid metabolism and their possible role on disease progression we studied a minipig model of HF. Methods: 13 adult male minipigs were chronically instrumented with a pacemaker connected to the left ventricular (LV) wall. Blood samples were collected: 1) prior device implantation, 2) at pacing activation (10 days after surgery), and 3) after three weeks of pacing activation, at 180 beats/min, when LV ejection fraction was <35% and end-diastolic pressure was >18 mmHg. At the same intervals, we also evaluated the differences in the cellular cholesterol efflux efficiency mediated by HDL. Results: After three weeks of pacing there were no significant changes in total cholesterol and triglycerides compared to baseline (57.7±16.0 vs 54.2±13.0 mg/dl and 31.7±7.6 vs 31.4±14.8 mg/dl respectively). Conversely, HDL and ApoA1 levels were dramatically decreased (24.5±8.0 vs 12.4±5.7 mg/dl, p<0.0001 and 20.9±9.3 vs 11.8±5.5 mg/dl, p<0.005 respectively). Among the inflammatory markers ceruplasmin levels were significantly increased (24.7±20.8 vs 83.9±54.6 mg/dl, p<0.005). After pacing-on efflux mediated by SRB1 and by gradient concentration (passive diffusion) are reduced compared to the basal levels (-38%, p<0.005 and -28%, p<0.05, respectively). No statistical change was observed analyzing the efflux mediated by ABCA1 and ABCG1. Conclusions: In this experimental model the HF induced a progressive reduction in HDL and ApoA1 plasma levels together with a reduced cellular cholesterol efflux mediated by passive diffusion and SRB1 ligand. This phenomenon could promote or facilitate the process leading to the full-blown dilated cardiomyopathy via mechanisms that surely deserve further studies.
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Does ICD-10 hospital discharge code I50 identify people with heart failure? a validation study within the EPIC-Norfolk study Aims: Hospital discharge registries are frequently used for identification of individuals with heart failure in large cohort studies. However, validity of discharge codes is heterogeneous across earlier studies and current data on European populations are sparse. We examined the validity of the ICD-10 discharge code I50 for heart failure in participants of the population-based EPIC-Norfolk study. Methods and results: Hospital records of a random subset of participants with a hospital discharge code I50 between 1997-2009 identified through a national hospital record linkage system were scrutinized for diagnostic criteria of heart failure according to recommendations of the European Society of Cardiology. Of 396 cases with records available for review 77.8% were classified as definite, 10.4% as probable, 7.6% as possible and 4.3% as no heart failure, i.e. 95.8% of cases had definitive, probable or possible diagnosis of heart failure. Of the 17 participants with no heart failure, 10 had evidence of LV-dysfunction or structural heart disease. The validity of I50 was similar in subgroups by age, gender, BMI and time period of hospitalization. Conclusion: Obtaining ICD-10 discharge code I50 through hospital record linkage provides a feasible and accurate method of identifying heart failure in contemporary cohort studies in the UK.
